Author

Max Zirngibl

University of FreiburgORCID 0009-0007-9311-1816Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Christoph SchelliD· 2 shared Grigor AndreeviD· 2 shared Manuel RoggiD· 2 shared Markus Tobias GrabbertiD· 2 shared Oliver SchillingiD· 2 shared Tobias FeileniD· 2 shared Andreas Nägel· 1 shared Anna L. KoessingeriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Christoph SchellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 23, 2026

Fibroblast-derived Collagen VI shapes the structure and function of the tumor-immune microenvironment in clear cell renal cell carcinoma

Maximilian Wess, Grigor Andreev, Tobias Feilen…·Christoph Schell

This study identifies collagen VI as a key ECM component in ccRCC stroma, showing its role in shaping tumor structure, function, and immune response, with implications for TKI therapy.

DOI 10.64898/2026.03.19.712351

humanproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintOct 23, 2025

Proteomic characterization of sporadic clear cell renal cell carcinoma reveals a matrix-dense pseudocapsule and heterogeneous tumor subtypes

Tobias Feilen, Grigor Andreev, Manuel Rogg…·Oliver Schilling

This study uses proteomics to characterize sporadic ccRCC, identifying a matrix-dense pseudocapsule and five tumor subtypes with distinct biological features.

DOI 10.1101/2025.10.23.683844

humanproteomics

𝕏 PostBluesky